352 related articles for article (PubMed ID: 23913591)
61. [Genetic and molecular bases of paragangliomas].
Núñez Lozano M; González Sarmiento R
Acta Otorrinolaringol Esp; 2009 Feb; 60 Suppl 1():24-8. PubMed ID: 19245772
[TBL] [Abstract][Full Text] [Related]
62. Back to Biochemistry: Evaluation for and Prognostic Significance of SDH Mutations in Paragangliomas and Pheochromocytomas.
Gupta S; Erickson LA
Surg Pathol Clin; 2023 Mar; 16(1):119-129. PubMed ID: 36739159
[TBL] [Abstract][Full Text] [Related]
63. Models of parent-of-origin tumorigenesis in hereditary paraganglioma.
Hoekstra AS; Devilee P; Bayley JP
Semin Cell Dev Biol; 2015 Jul; 43():117-124. PubMed ID: 26067997
[TBL] [Abstract][Full Text] [Related]
64. Germline SDHB mutations and familial renal cell carcinoma.
Ricketts C; Woodward ER; Killick P; Morris MR; Astuti D; Latif F; Maher ER
J Natl Cancer Inst; 2008 Sep; 100(17):1260-2. PubMed ID: 18728283
[TBL] [Abstract][Full Text] [Related]
65. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma.
Buffet A; Burnichon N; Favier J; Gimenez-Roqueplo AP
Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101416. PubMed ID: 32295730
[TBL] [Abstract][Full Text] [Related]
66. SDHx gene detection and clinical Phenotypic analysis of multiple paraganglioma in the head and neck.
Ding Y; Feng Y; Wells M; Huang Z; Chen X
Laryngoscope; 2019 Feb; 129(2):E67-E71. PubMed ID: 30484866
[TBL] [Abstract][Full Text] [Related]
67. Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma.
Cascon A; Ruiz-Llorente S; Cebrian A; Telleria D; Rivero JC; Diez JJ; Lopez-Ibarra PJ; Jaunsolo MA; Benitez J; Robledo M
Eur J Hum Genet; 2002 Aug; 10(8):457-61. PubMed ID: 12111639
[TBL] [Abstract][Full Text] [Related]
68. Parasympathetic paragangliomas are part of the Von Hippel-Lindau syndrome.
Gaal J; van Nederveen FH; Erlic Z; Korpershoek E; Oldenburg R; Boedeker CC; Kontny U; Neumann HP; Dinjens WN; de Krijger RR
J Clin Endocrinol Metab; 2009 Nov; 94(11):4367-71. PubMed ID: 19808854
[TBL] [Abstract][Full Text] [Related]
69. [Hereditary pheochromocytoma and paraganglioma: screening and follow-up strategies in asymptomatic mutation carriers].
Vermalle M; Tabarin A; Castinetti F
Ann Endocrinol (Paris); 2018 Sep; 79 Suppl 1():S10-S21. PubMed ID: 30213301
[TBL] [Abstract][Full Text] [Related]
70. Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature Review.
Casey RT; Warren AY; Martin JE; Challis BG; Rattenberry E; Whitworth J; Andrews KA; Roberts T; Clark GR; West H; Smith PS; Docquier FM; Rodger F; Murray V; Simpson HL; Wallis Y; Giger O; Tran M; Tomkins S; Stewart GD; Park SM; Woodward ER; Maher ER
J Clin Endocrinol Metab; 2017 Nov; 102(11):4013-4022. PubMed ID: 28973655
[TBL] [Abstract][Full Text] [Related]
71. [From gene to disease; from SDHD, a defect in the respiratory chain, to paragangliomas and pheochromocytomas].
Taschner PE; Bröcker-Vriends AH; van der Mey AG
Ned Tijdschr Geneeskd; 2002 Nov; 146(46):2188-90. PubMed ID: 12467161
[TBL] [Abstract][Full Text] [Related]
72. Chromosomal changes in sporadic and familial head and neck paragangliomas.
Sevilla MA; Hermsen MA; Weiss MM; Grimbergen A; Balbín M; Llorente JL; Rodrigo JP; Suárez C
Otolaryngol Head Neck Surg; 2009 May; 140(5):724-9. PubMed ID: 19393419
[TBL] [Abstract][Full Text] [Related]
73. Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.
Rednam SP; Erez A; Druker H; Janeway KA; Kamihara J; Kohlmann WK; Nathanson KL; States LJ; Tomlinson GE; Villani A; Voss SD; Schiffman JD; Wasserman JD
Clin Cancer Res; 2017 Jun; 23(12):e68-e75. PubMed ID: 28620007
[TBL] [Abstract][Full Text] [Related]
74. The phenotype of
Niemeijer ND; Rijken JA; Eijkelenkamp K; van der Horst-Schrivers ANA; Kerstens MN; Tops CMJ; van Berkel A; Timmers HJLM; Kunst HPM; Leemans CR; Bisschop PH; Dreijerink KMA; van Dooren MF; Bayley JP; Pereira AM; Jansen JC; Hes FJ; Hensen EF; Corssmit EPM
Eur J Endocrinol; 2017 Aug; 177(2):115-125. PubMed ID: 28490599
[TBL] [Abstract][Full Text] [Related]
75. Malignant head and neck paragangliomas in SDHB mutation carriers.
Boedeker CC; Neumann HP; Maier W; Bausch B; Schipper J; Ridder GJ
Otolaryngol Head Neck Surg; 2007 Jul; 137(1):126-9. PubMed ID: 17599579
[TBL] [Abstract][Full Text] [Related]
76. [Hereditary pheochromocytoma and paraganglioma].
Musil Z; Vícha A; Zelinka T; Turková H; Labudová T; Kohoutová M; Pacák K
Klin Onkol; 2012; 25 Suppl():S21-6. PubMed ID: 22920202
[TBL] [Abstract][Full Text] [Related]
77. The malignant potential of a succinate dehydrogenase subunit B germline mutation.
Fuentes C; Menéndez E; Pineda J; Martínez De Esteban JP; Anda E; Goñi MJ; Bausch B; Neumann HP
J Endocrinol Invest; 2006 Apr; 29(4):350-2. PubMed ID: 16699302
[TBL] [Abstract][Full Text] [Related]
78. Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.
Pollard PJ; El-Bahrawy M; Poulsom R; Elia G; Killick P; Kelly G; Hunt T; Jeffery R; Seedhar P; Barwell J; Latif F; Gleeson MJ; Hodgson SV; Stamp GW; Tomlinson IP; Maher ER
J Clin Endocrinol Metab; 2006 Nov; 91(11):4593-8. PubMed ID: 16954163
[TBL] [Abstract][Full Text] [Related]
79. The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications.
Stratakis CA; Carney JA
J Intern Med; 2009 Jul; 266(1):43-52. PubMed ID: 19522824
[TBL] [Abstract][Full Text] [Related]
80. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]